These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 5785198)

  • 41. [Effect of a new drug association on hypercholesteremia studied with a controlled clinical trial].
    Manaresi A
    Clin Ter; 1971 Mar; 56(6):523-34. PubMed ID: 5131092
    [No Abstract]   [Full Text] [Related]  

  • 42. Mexiletine in the treatment of ventricular arrhythmias.
    Henrard L; Carlier J
    Acta Cardiol Suppl; 1980; (25):127-35. PubMed ID: 6966452
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Efficacy of mexiletine in the treatment of ventricular arrhythmia in patients with conduction disorders and sick sinus syndrome].
    González Zuelgaray J; Nieves E; Fernández R; Posse RA
    Medicina (B Aires); 1982; 42(5):483-7. PubMed ID: 7169943
    [No Abstract]   [Full Text] [Related]  

  • 44. [A new anti-arrhythmia drug--profpafenon--in ventricular arrhythmias in the coronary unit].
    Figueira RH
    Arq Bras Cardiol; 1979 Sep; 33(3):233-9. PubMed ID: 543813
    [No Abstract]   [Full Text] [Related]  

  • 45. [Use of practolol in arrhythmia].
    Bracchetti D; Russo F; Accorsi A
    G Clin Med; 1971 Jun; 52(6):446-74. PubMed ID: 4401175
    [No Abstract]   [Full Text] [Related]  

  • 46. Comparative study of propranolol and practolol with non-invasive methods in essential circulatory hyperkinesis.
    Matos L; Török E; Németh J; Békés M
    Int J Clin Pharmacol; 1972 Jun; 6(2):150-60. PubMed ID: 4404773
    [No Abstract]   [Full Text] [Related]  

  • 47. [Mexitil in the treatment of ventricular arrhythmia (personal experiences)].
    Dłuzniewski M; Zalewski A; Grochowicz U; Chamiec T
    Kardiol Pol; 1983; 26(8-9):657-62. PubMed ID: 6363796
    [No Abstract]   [Full Text] [Related]  

  • 48. [Clinical experience with oxyphedrine in the treatment of ischemic cardiopathy].
    Almeida SP
    Rev Bras Med; 1971 Dec; 28(12):644-52. PubMed ID: 5145755
    [No Abstract]   [Full Text] [Related]  

  • 49. [Mexiletine, a new anti-arrhythmic, in the treatment of ventricular arrhythmia].
    Menozzi C; Brignole M; Monducci I; Lolli G; Vergoni W; Guiducci U; Bertulla A
    Clin Ter; 1982 Jan; 100(2):175-88. PubMed ID: 7186423
    [No Abstract]   [Full Text] [Related]  

  • 50. [Therapeutic results with the cardioselective beta-blocker ICI 50 172 in coronary insufficiency].
    Westermann KW; Kaparis G
    Verh Dtsch Ges Inn Med; 1971; 77():943-5. PubMed ID: 4405364
    [No Abstract]   [Full Text] [Related]  

  • 51. [Therapeutic experiences with LB-46 (a new anti-arrhythmic agent) on arrhythmia during general anesthesia].
    Tosaki Y; Yoshiya I; Yoshikawa K; Onji Y
    Masui; 1971 Jan; 20(1):74-9. PubMed ID: 5102309
    [No Abstract]   [Full Text] [Related]  

  • 52. [Intravenous practolol test].
    Sterkowicz S
    Pol Tyg Lek; 1973 Jan; 28(4):125-7. PubMed ID: 4405676
    [No Abstract]   [Full Text] [Related]  

  • 53. Practolol in the management of cardiac dysrhythmias in patients anaesthetized with halothane.
    Mathias JA; Payne JP
    Br J Pharmacol; 1970 Nov; 40(3):572P-573P. PubMed ID: 5531865
    [No Abstract]   [Full Text] [Related]  

  • 54. [Effectiveness of mexiletine in arrhythmia of effort].
    Zacà F; Cremonesi A; Pagliarani PL; Guelfi P; Bugiardini R; Lasagna I; Ghinelli M; Luciani G
    Minerva Cardioangiol; 1981 Nov; 29(11):655-60. PubMed ID: 6173818
    [No Abstract]   [Full Text] [Related]  

  • 55. [Antiarrhythmic efficacy of mexiletine in supraventricular arrhythmias, Wolff-Parkinson-White syndrome and persistent iterative ventricular hyperkinetic arrhythmias. Considerations on these less noted therapeutic effects].
    Menozzi C; Lolli G; Monducci I; Gheller G; Brignole M; Cattabiani ML; Vergoni W; Barone A
    Clin Ter; 1984 Feb; 108(3):199-208. PubMed ID: 6232057
    [No Abstract]   [Full Text] [Related]  

  • 56. Chaotic atrial rhythms. Clinical and electrophysiological observations.
    Gavrilescu S; Cotoi S; Pop T
    G Ital Cardiol; 1971; 1(5):388-400. PubMed ID: 5132624
    [No Abstract]   [Full Text] [Related]  

  • 57. [Experience with the use of the beta-receptor blocker practolol (Dalzic) in anesthesia (gynecology)].
    Schilling K
    Z Prakt Anasth Wiederbeleb Intensivther; 1972 Dec; 7(6):367-77. PubMed ID: 4405592
    [No Abstract]   [Full Text] [Related]  

  • 58. [Recent acquisitions in the therapy of arterial hypertension].
    Luccioni R; Sebaoun E
    Therapeutique; 1971 Dec; 47(10):903-5. PubMed ID: 5145558
    [No Abstract]   [Full Text] [Related]  

  • 59. [On the mechanism of the antiarrhythmic effect of beta-adrenergic receptor blocking drugs. Experimental research using 2 isomers of butidrin].
    Mastandrea R; Malagnino G; Astorri E; Visoli O
    Boll Soc Ital Cardiol; 1967; 12(5):525-8. PubMed ID: 5606898
    [No Abstract]   [Full Text] [Related]  

  • 60. [Use of a beta sympatholytic agent (Trimepranol) in thyrotoxicosis].
    Blehová B; Bleha O; Hníková O; Polák E
    Cesk Pediatr; 1971 Jan; 26(1):41-3. PubMed ID: 4395985
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.